MediciNova, Inc. (MNOV) vs Neumora Therapeutics, Inc. (NMRA)
MediciNova, Inc. and Neumora Therapeutics, Inc. are both Biotechnology companies. MediciNova, Inc. and Neumora Therapeutics, Inc. are of similar size ($135.3M and $132.9M). Neumora Therapeutics, Inc. has the higher net margin (0.00% vs −1,168.3%) and the higher return on invested capital (0.00% vs −62.5%). Across the 14 metrics below, MediciNova, Inc. leads on 7 and Neumora Therapeutics, Inc. on 7.
Valuation
Profitability
| Metric | MNOV | NMRA | Biotechnology median |
|---|---|---|---|
| Gross margin | 37.76% | 0.00% | 65.16% |
| Operating margin | (1,287.53%) | 0.00% | 0.00% |
| Net margin | (1,168.31%) | 0.00% | 0.00% |
| Free cash flow margin | (991.31%) | 0.00% | 0.00% |
| Return on equity | (25.56%) | (187.11%) | (57.72%) |
| Return on assets | (23.83%) | (121.89%) | (49.22%) |
| Return on invested capital | (62.48%) | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack